Tvardi Therapeutics Balance Sheet (2013-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)			1.16M				1.41M				1.67M
Receivables - Accured (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)	22.34M	22.99M	13.45M	21.36M	46.72M	42.81M	63.74M	47.39M	58.25M	62.88M	51.77M	47.00M	49.24M	37.06M	31.61M	34.22M	20.60M	21.40M	20.73M	19.85M
Receivables - Net (Quarter)		20.03M								3.35M	2.77M	1.72M	0.36M	0.43M		1.23M
Receivables - Other (Quarter)	0.30M	20.05M	-19.89M	0.44M	8.00M	9.62M	0.04M	6.07M	10.12M	1.68M	-1.13M	0.51M	0.76M	0.93M	0.66M	1.01M
Receivables (Quarter)	0.30M	40.08M	-19.89M	0.44M	8.00M	9.62M	0.04M	6.07M	10.12M	5.03M	1.64M	2.22M	1.12M	1.37M	0.66M	2.24M
Raw Materials (Quarter)			0.93M	1.09M	1.82M	1.83M
Work In Process (Quarter)			1.66M	0.81M	0.64M	0.00M
Finished Goods (Quarter)					1.00M
Inventory (Quarter)			2.58M	1.91M	3.46M	1.83M	2.38M	3.52M	3.42M	3.30M	3.35M	2.79M	1.64M	2.14M	0.90M	2.42M
Prepaid Assets (Quarter)	8.29M	6.26M	0.67M	5.11M	0.83M	0.61M	16.27M	17.20M	1.01M	0.66M	8.15M	0.47M	0.30M	2.38M	0.05M	1.59M	0.25M	0.37M	0.23M	0.34M
Current Assets (Quarter)	164.47M	171.50M	173.29M	151.76M	176.17M	186.78M	168.91M	142.66M	124.74M	100.60M	116.16M	81.22M	63.86M	47.91M	31.69M		43.13M	38.44M	31.54M	25.33M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.72M	0.65M	0.63M	0.61M	0.55M	0.49M	0.43M	0.37M	0.31M	1.38M	3.32M	3.55M	3.49M	3.42M	0.08M		0.07M	0.06M	0.05M	0.04M
Long-Term Investments (Quarter)	52.22M	49.22M	69.75M	68.46M	47.17M	23.92M	11.35M	9.07M	7.05M	4.75M
Intangibles (Quarter)															0.39M		0.35M	0.34M	0.32M	0.31M
Goodwill & Intangibles (Quarter)															0.39M		0.35M	0.34M	0.32M	0.31M
Long-Term Deferred Tax (Quarter)															2.80M
Other Non-Current Assets (Quarter)	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M			1.50M	1.50M	1.50M	1.50M	1.50M		0.02M		0.02M	0.02M	0.02M	0.02M
Non-Current Assets (Quarter)	56.98M	53.59M	73.77M	72.10M	50.41M	26.73M	13.33M	10.62M	9.65M	14.73M	9.69M	8.87M	8.64M	3.42M	3.51M		0.62M	0.58M	0.54M	0.49M
Assets (Quarter)	221.45M	225.09M	247.06M	223.87M	226.57M	213.51M	182.24M	153.28M	134.39M	115.34M	125.84M	90.10M	72.50M	51.33M	35.20M	38.95M	43.75M	39.02M	32.07M	25.82M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	13.49M	5.37M	15.86M	16.50M	19.33M	26.32M	21.54M	15.22M	24.48M	22.38M	25.59M	4.98M	13.73M	6.62M	2.19M	1.20M	2.42M	4.08M	3.22M	4.62M
Payables (Quarter)	13.49M	5.37M	15.86M	16.50M	19.33M	26.32M	21.54M	15.22M	24.48M	22.38M	25.59M	4.98M	13.73M	6.62M	2.19M	1.20M	2.42M	4.08M	3.22M	4.62M
Accumulated Expenses (Quarter)	3.15M	4.12M	4.96M	2.41M	3.35M	4.23M	5.22M	2.95M	4.20M	5.37M	6.52M	2.06M	1.21M	1.17M	1.14M	0.61M	0.74M	1.01M	1.30M	6.52M
Other Accumulated Expenses (Quarter)															0.01M		0.45M	0.45M	0.32M	0.18M
Current Leases (Quarter)	1.68M	1.72M	1.75M	1.79M	1.83M	1.88M	1.92M	1.46M	0.98M	0.50M		0.22M	0.17M	3.42M	0.10M		0.11M	0.11M	0.12M	0.12M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	15.17M	15.53M	17.62M	18.30M	21.17M	28.19M	23.46M	16.68M	25.46M	22.88M	25.59M	15.10M	13.90M	10.04M	10.37M	1.20M	10.68M	11.04M	11.04M	11.26M
Non-Current Liabilities
Convertible Debt (Quarter)															30.26M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)											85.50M	85.50M	85.50M	85.50M	85.50M	85.50M
Operating Leases (Quarter)	2.82M	2.37M	1.92M	1.46M	0.98M	0.50M				6.82M	6.09M	6.83M	7.32M		0.20M		0.14M	0.12M	0.09M	0.05M
Other Non-Current Liabilities (Quarter)											37.08M	38.38M	39.68M	40.58M	44.45M	45.82M
Total Non-Current Liabilities (Quarter)											31.68M	21.92M	21.22M	10.04M	-3.62M	1.20M			11.13M	11.31M
Total Liabilities (Quarter)	221.45M	225.09M	247.06M	223.87M	226.57M	213.51M	23.46M	153.28M	134.39M	115.34M	68.76M	60.30M	60.90M	50.62M	40.83M	47.02M	10.82M	11.15M	11.13M	11.31M
Shareholder's Equity
Common Equity (Quarter)	203.47M	207.19M	227.52M	204.12M	204.42M	184.82M	158.78M	136.60M	108.93M	85.64M	-62.06M	-66.17M	-73.07M	-78.50M	-91.13M	-100.62M	32.93M	27.87M	20.95M	14.51M
Liabilities and Shareholders Equity (Quarter)	221.45M	225.09M	247.06M	223.87M	226.57M	213.51M	182.24M	153.28M	134.39M	115.34M	125.84M	90.10M	72.50M	51.33M	35.20M	38.95M	43.75M	39.02M	32.07M	25.82M
Retained Earnings (Quarter)	-0.01M	0.00M	-0.36M	-1.72M	-512.71M	-535.89M	-566.23M	-592.90M	-624.38M	-652.41M	-684.75M	-0.19M	-0.12M	-747.93M	-92.24M	-760.52M	-0.01M	-103.20M	0.01M	131.75M
Treasury Shares (Quarter)	0.41M	0.37M	0.58M	0.74M	0.65M	0.64M	0.03M	0.70M	0.79M	0.78M	0.05M	0.01M	0.98M	0.97M	3.96M	0.03M

Research Tools

Datasets

Plans

Developers

Tvardi Therapeutics TVRD Balance Sheet (2013-2026)

Research Tools

Datasets

Plans

Developers

Tvardi Therapeutics TVRD Balance Sheet (2013-2026)

Create an account

Sign In

Reset Password